MSc candidate, Helen Jin, attended the 2020 Euroleuk Conference on behalf of the DaCosta lab this October 28-29. The meeting provided clinicians and biologists with state-of-the-art recommendations regarding patient care and insights into controversies and new therapeutic perspectives in the field of leukemia.
Helen presented a poster and an oral presentation entitled “Preclinical Evaluation of a Novel Cell-Based IL12 Immunotherapy for Acute Lymphoblastic Leukemia”. Her outstanding abstract was judged to be one of the top three best abstracts submitted!